BOSTON, Oct. 7 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. is pleased to announce that its MammoView(TM) line of surgical endoscopy instruments will be demonstrated at the 95th Annual American College of Surgeons Clinical Congress, held October 11th-15th in Chicago, Illinois. During the Breast Ductoscopy for the General Surgeon course, postgraduate surgeons will be given lectures and access to hands-on skill stations that will provide the core knowledge base required to perform breast duct endoscopy (ductoscopy) in the practice setting. Four of the six offered skill stations, during this course, will feature the MammoView(TM) line of surgical endoscopy instruments.
The Clinical Congress of the American College of Surgeons continues to remain the premier U.S. annual surgical meeting that provides a vast array of educational and networking opportunities. Programs at the Clinical Congress are developed to advance surgeons’ ongoing efforts to achieve the best clinical outcomes for their patients. This year’s Congress will feature 116 panel sessions, video-based education selections, and hundreds of scientific exhibits and technical exhibits from a wide variety of companies. The Skills-Oriented Postgraduate Courses will focus on important domains and help attendees advance their knowledge and acquire new skills. Experiential, hands-on learning will be used to achieve the course objectives.
“We are proud to have our MammoView(TM) line of surgical endoscopy instruments demonstrated at the 95th Annual American College of Surgeons Clinical Congress and are excited by the exposure it will receive. As more doctors become familiar and educated in using our product line, when performing breast ductoscopy, we believe that this can only result in an increased demand for the MammoView(TM) line,” stated Bob Segersten, President of Solos Endoscopy, Inc.
For more information on the 95th Annual American College of Surgeons Clinical Congress, please visit: http://www.facs.org/clincon2009/index.html.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos’ sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company’s website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
CONTACT: Investor Relations of Big Apple Consulting USA, +1-407-389-5900
Web site: http://www.solosendoscopy.com/
